# IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer

> **NCT04854590** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 248 (actual)

## Conditions studied

- Carcinoma, Small Cell

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT04854590
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-22
- **Primary completion:** 2023-07-25
- **Final completion:** 2023-07-25
- **Target enrollment:** 248 (ACTUAL)
- **Last updated:** 2024-07-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04854590

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04854590, "IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04854590. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*